Enlibrium's Series A Round

Enlibrium raised a round of funding on December 04, 2015.

Enlibrium is developing novel drugs based on metformin to treat a range of different cancers by reducing cancer energy consumption and reestablishing energy balance. Given their high growth rate and e…

Articles about Enlibrium's Series A Round: